Mithra Pharmaceuticals saw no growth in patent filings and highest growth of 2.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 2.99%. GlobalData’s DataBook provides a comprehensive analysis of Mithra Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Mithra Pharmaceuticals has been focused on protecting inventions in United States(US) with two publications in Q2 2024
The United States(US) Patent Office dominates the patent grants with nearly 50% of grants. The World Intellectual Property Organization(WIPO), United States(US), Brazil(BR), and Spain(ES) patent Office are among the top ten patent offices where Mithra Pharmaceuticals is filings its patents. Among the top granted patent authorities, Mithra Pharmaceuticals has 50% of its grants in United States(US), 25% in Brazil(BR) and 25% in Spain(ES).
AbbVie and Roche could be the strongest competitors for Mithra Pharmaceuticals
Patents related to rare diseases lead Mithra Pharmaceuticals's portfolio
Mithra Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Hormone replacement therapy (hrt) related patents lead Mithra Pharmaceuticals portfolio followed by female contraception, and mobiles, hand-helds, pdas, smartphones
Mithra Pharmaceuticals has highest number of patents in hormone replacement therapy (hrt) followed by female contraception, mobiles, hand-helds, pdas, smartphones, general surgery devices, and wounds.
For comprehensive analysis of Mithra Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
